Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Theresa Grover

Concepts (345)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Intensive Care Units, Neonatal
36
2026
279
4.100
 Why?
Hernias, Diaphragmatic, Congenital
18
2026
219
3.970
 Why?
Extracorporeal Membrane Oxygenation
9
2026
383
1.710
 Why?
Infant, Newborn
61
2026
6429
1.600
 Why?
Infant, Premature
14
2025
611
1.530
 Why?
Catheterization, Central Venous
6
2025
122
1.350
 Why?
Cross Infection
3
2025
262
1.300
 Why?
Bacterial Infections
2
2025
246
1.240
 Why?
Bronchopulmonary Dysplasia
10
2024
410
1.090
 Why?
Central Venous Catheters
5
2025
52
1.030
 Why?
Urinary Tract Infections
4
2025
202
1.030
 Why?
Pulmonary Circulation
15
2011
430
0.910
 Why?
Gestational Age
17
2025
975
0.900
 Why?
Length of Stay
12
2026
1337
0.880
 Why?
Enteral Nutrition
4
2025
216
0.850
 Why?
Mycoses
1
2025
88
0.850
 Why?
Catheter-Related Infections
4
2017
94
0.750
 Why?
Gastroschisis
4
2025
32
0.700
 Why?
Quality Improvement
9
2024
1289
0.600
 Why?
Catheterization, Peripheral
1
2021
118
0.600
 Why?
Hypertension, Pulmonary
11
2021
1980
0.600
 Why?
Bottle Feeding
1
2019
19
0.590
 Why?
Fetus
14
2020
803
0.580
 Why?
Infant
27
2026
10034
0.570
 Why?
Infant Formula
1
2019
71
0.560
 Why?
Retrospective Studies
33
2026
17066
0.560
 Why?
Hospitals, Pediatric
6
2025
556
0.560
 Why?
Vascular Endothelial Growth Factor A
6
2007
557
0.550
 Why?
Bacteremia
4
2024
221
0.530
 Why?
Practice Guidelines as Topic
6
2024
1560
0.530
 Why?
Postoperative Complications
5
2025
2919
0.520
 Why?
Lung
10
2011
4109
0.510
 Why?
Parenteral Nutrition, Total
1
2017
30
0.510
 Why?
Vasodilation
11
2011
523
0.490
 Why?
Weight Gain
2
2017
556
0.480
 Why?
Sheep
20
2011
880
0.480
 Why?
Intensive Care, Neonatal
4
2020
42
0.450
 Why?
High-Frequency Ventilation
1
2015
45
0.450
 Why?
Infant, Premature, Diseases
2
2024
111
0.430
 Why?
Intersectoral Collaboration
1
2015
62
0.430
 Why?
Developmental Disabilities
1
2018
281
0.430
 Why?
Patient Education as Topic
1
2019
780
0.400
 Why?
Nitric Oxide Synthase
9
2006
235
0.390
 Why?
Tracheostomy
3
2024
142
0.390
 Why?
Humans
64
2026
144759
0.380
 Why?
Endothelial Growth Factors
2
2002
64
0.380
 Why?
Lymphokines
2
2002
130
0.370
 Why?
Anti-Bacterial Agents
4
2024
1907
0.370
 Why?
Female
54
2026
78271
0.370
 Why?
Hospitalization
3
2021
2433
0.360
 Why?
Nitric Oxide
10
2011
897
0.350
 Why?
Patient Discharge
6
2025
983
0.350
 Why?
Surgical Procedures, Operative
1
2014
270
0.340
 Why?
Intercellular Signaling Peptides and Proteins
2
2002
381
0.330
 Why?
Pulmonary Artery
11
2011
1134
0.320
 Why?
Parents
1
2019
1403
0.310
 Why?
Intubation, Intratracheal
2
2024
320
0.310
 Why?
Respiration, Artificial
6
2026
708
0.300
 Why?
Male
33
2026
72315
0.300
 Why?
Databases, Factual
7
2025
1486
0.290
 Why?
Hospital Mortality
4
2026
1030
0.290
 Why?
Persistent Fetal Circulation Syndrome
2
2011
138
0.290
 Why?
Anesthesia
2
2023
258
0.290
 Why?
Pregnancy
23
2021
7190
0.270
 Why?
Survival Rate
4
2018
2089
0.270
 Why?
Patient Care Bundles
2
2019
28
0.260
 Why?
Lung Diseases
1
2014
787
0.260
 Why?
Infant Mortality
2
2026
123
0.250
 Why?
Nitric Oxide Synthase Type III
6
2007
204
0.250
 Why?
Guideline Adherence
4
2025
589
0.250
 Why?
Fibrin
1
2007
91
0.240
 Why?
Fetal Diseases
3
2004
191
0.240
 Why?
Intestinal Atresia
1
2025
17
0.230
 Why?
Urea Cycle Disorders, Inborn
1
2026
26
0.230
 Why?
Hernia, Diaphragmatic
1
2026
67
0.230
 Why?
Jejunum
1
2025
35
0.230
 Why?
Hospitals, High-Volume
1
2026
49
0.230
 Why?
Guanylate Cyclase
4
2011
39
0.230
 Why?
Multivariate Analysis
5
2025
1539
0.230
 Why?
Logistic Models
6
2025
2117
0.230
 Why?
Heart Defects, Congenital
2
2026
914
0.230
 Why?
Pulmonary Alveoli
2
2005
383
0.230
 Why?
Infection Control
2
2017
172
0.220
 Why?
Ileum
1
2025
111
0.220
 Why?
Bradycardia
2
2024
59
0.220
 Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2007
297
0.220
 Why?
Anastomotic Leak
1
2024
44
0.210
 Why?
Ductus Arteriosus, Patent
1
2025
50
0.210
 Why?
Ventilator Weaning
1
2024
39
0.210
 Why?
Consensus
2
2024
488
0.210
 Why?
Esophageal Atresia
1
2024
30
0.210
 Why?
Device Removal
1
2025
143
0.210
 Why?
North America
1
2025
310
0.210
 Why?
Stenosis, Pulmonary Vein
1
2024
19
0.210
 Why?
Tracheoesophageal Fistula
1
2024
38
0.210
 Why?
Blood Culture
1
2024
25
0.210
 Why?
Critical Pathways
1
2025
108
0.210
 Why?
Cyclic GMP
4
2011
92
0.200
 Why?
Clinical Protocols
1
2025
282
0.200
 Why?
Severity of Illness Index
6
2026
2925
0.200
 Why?
Laryngoscopy
1
2024
117
0.200
 Why?
Ductus Arteriosus
6
2008
72
0.190
 Why?
Neovascularization, Pathologic
1
2004
286
0.190
 Why?
Delphi Technique
1
2024
329
0.180
 Why?
Hemangioendothelioma
1
2002
13
0.180
 Why?
Infant, Newborn, Diseases
1
2023
113
0.180
 Why?
Infant, Small for Gestational Age
2
2025
109
0.170
 Why?
Time Factors
7
2024
7173
0.170
 Why?
Uterus
1
2002
226
0.170
 Why?
Patient Handoff
1
2021
42
0.170
 Why?
Retrognathia
1
2020
4
0.170
 Why?
Hepatitis B Vaccines
1
2021
43
0.170
 Why?
Animals, Newborn
7
2009
902
0.160
 Why?
Micrognathism
1
2020
19
0.160
 Why?
Neuromuscular Blockade
1
2021
51
0.160
 Why?
Hepatitis B
1
2021
66
0.160
 Why?
Betamethasone
1
2000
21
0.160
 Why?
Benzoates
2
2011
50
0.160
 Why?
Social Determinants of Health
1
2024
301
0.160
 Why?
Analgesia
1
2021
105
0.160
 Why?
Vascular Resistance
6
2011
367
0.160
 Why?
Ventricular Septum
1
2019
8
0.150
 Why?
Carbon Monoxide
1
2000
82
0.150
 Why?
Hypothermia
1
2020
52
0.150
 Why?
Incidence
2
2018
2879
0.150
 Why?
United States
7
2025
15966
0.150
 Why?
Cooperative Behavior
3
2017
465
0.150
 Why?
Food, Fortified
1
2019
44
0.150
 Why?
Geographic Mapping
1
2019
29
0.140
 Why?
Neonatology
1
2019
28
0.140
 Why?
Blood Pressure
5
2019
1769
0.140
 Why?
Airway Obstruction
1
2020
162
0.140
 Why?
Receptors, Cytoplasmic and Nuclear
2
2011
209
0.140
 Why?
Endothelium, Vascular
1
2005
965
0.140
 Why?
Recombinant Proteins
4
2005
1370
0.140
 Why?
Animals
22
2011
38058
0.140
 Why?
Community-Acquired Infections
1
2020
174
0.140
 Why?
Respiratory Insufficiency
1
2021
326
0.140
 Why?
Housing
1
2019
144
0.130
 Why?
Echocardiography, Doppler
1
2018
115
0.130
 Why?
Perioperative Care
1
2020
231
0.130
 Why?
Odds Ratio
2
2020
1075
0.130
 Why?
Cardiopulmonary Resuscitation
1
2020
340
0.130
 Why?
Infant, Very Low Birth Weight
1
2017
73
0.120
 Why?
Premature Birth
1
2020
380
0.120
 Why?
Continuity of Patient Care
1
2019
291
0.120
 Why?
Heart Arrest
1
2020
407
0.120
 Why?
Echocardiography
1
2019
652
0.120
 Why?
Infant, Extremely Premature
1
2017
67
0.120
 Why?
Disease Models, Animal
6
2011
4557
0.120
 Why?
Patient Transfer
1
2019
206
0.120
 Why?
Patient Readmission
2
2019
758
0.120
 Why?
Hemodynamics
6
2011
1121
0.120
 Why?
Glucocorticoids
1
2000
535
0.120
 Why?
Child
8
2023
22633
0.120
 Why?
Antimicrobial Stewardship
1
2018
129
0.120
 Why?
Risk Adjustment
1
2016
85
0.110
 Why?
Vasoconstriction
2
2008
217
0.110
 Why?
Clinical Nursing Research
1
2015
13
0.110
 Why?
Ligation
3
2025
92
0.110
 Why?
Liver Neoplasms
1
2002
780
0.110
 Why?
Communication
1
2021
965
0.110
 Why?
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
3
2011
28
0.110
 Why?
Enterocolitis, Necrotizing
2
2024
41
0.100
 Why?
Enzyme Activation
3
2005
766
0.100
 Why?
Nitroarginine
5
2006
57
0.100
 Why?
rho-Associated Kinases
3
2011
83
0.100
 Why?
Pregnancy Complications, Cardiovascular
2
2004
83
0.100
 Why?
Premedication
2
2024
42
0.100
 Why?
Program Evaluation
1
2017
948
0.100
 Why?
Vascular Endothelial Growth Factors
2
2002
80
0.090
 Why?
Linear Models
2
2025
854
0.090
 Why?
Heart Septal Defects, Ventricular
2
2026
46
0.090
 Why?
Administration, Inhalation
2
2007
574
0.090
 Why?
Mothers
1
2019
775
0.090
 Why?
Isoenzymes
2
2011
299
0.090
 Why?
Vasodilator Agents
2
2011
331
0.090
 Why?
Pneumonia
1
2018
631
0.090
 Why?
Apgar Score
2
2023
20
0.090
 Why?
Enzyme Inhibitors
5
2009
824
0.080
 Why?
Leadership
1
2015
408
0.080
 Why?
Health Services Accessibility
1
2019
1098
0.080
 Why?
Sulfones
3
2005
127
0.080
 Why?
Pyridines
4
2011
605
0.080
 Why?
Infant, Low Birth Weight
2
2022
153
0.080
 Why?
Chronic Disease
2
2014
1813
0.080
 Why?
Prevalence
3
2024
2834
0.080
 Why?
Myocytes, Smooth Muscle
1
2011
266
0.080
 Why?
Treatment Outcome
5
2025
11679
0.070
 Why?
Serotonin
1
2011
293
0.070
 Why?
Magnetic Resonance Imaging
1
2022
3863
0.070
 Why?
Risk Factors
4
2025
10779
0.070
 Why?
Pulmonary Wedge Pressure
2
2009
67
0.070
 Why?
Amides
2
2006
101
0.070
 Why?
Cohort Studies
4
2021
5960
0.070
 Why?
Muscle, Smooth, Vascular
3
2009
452
0.070
 Why?
Immunohistochemistry
2
2002
1716
0.060
 Why?
Procollagen-Proline Dioxygenase
1
2007
27
0.060
 Why?
Estradiol
2
2001
533
0.060
 Why?
Immediate-Early Proteins
1
2007
48
0.060
 Why?
Cardiovascular Agents
1
2008
164
0.060
 Why?
Oxadiazoles
3
2011
37
0.060
 Why?
Comorbidity
2
2024
1658
0.060
 Why?
Case-Control Studies
2
2024
3604
0.060
 Why?
Hospitals, Low-Volume
1
2026
25
0.060
 Why?
Selenium
1
2025
49
0.060
 Why?
Hydroxyeicosatetraenoic Acids
1
2005
35
0.060
 Why?
Renal Replacement Therapy
1
2026
100
0.060
 Why?
Protein Kinase Inhibitors
2
2008
969
0.050
 Why?
Thoracoscopy
1
2024
62
0.050
 Why?
Chylothorax
1
2024
20
0.050
 Why?
Abnormalities, Multiple
1
2026
197
0.050
 Why?
Antibiotic Prophylaxis
1
2025
129
0.050
 Why?
Hyperoxia
1
2005
99
0.050
 Why?
Pyrazoles
2
2005
509
0.050
 Why?
Anastomosis, Surgical
1
2024
157
0.050
 Why?
Birth Weight
1
2007
522
0.050
 Why?
Continuous Positive Airway Pressure
1
2024
88
0.050
 Why?
Body Weight
2
2005
976
0.050
 Why?
Noninvasive Ventilation
1
2024
62
0.050
 Why?
Video Recording
1
2024
212
0.050
 Why?
Intracellular Signaling Peptides and Proteins
1
2006
459
0.050
 Why?
Parenteral Nutrition
1
2024
105
0.050
 Why?
Homeodomain Proteins
1
2007
523
0.050
 Why?
Chromones
1
2002
42
0.050
 Why?
Platelet-Derived Growth Factor
1
2003
90
0.050
 Why?
Receptors, Vascular Endothelial Growth Factor
1
2002
109
0.050
 Why?
Acetaminophen
1
2025
264
0.050
 Why?
Morpholines
1
2002
128
0.040
 Why?
Clinical Trials as Topic
1
2007
1053
0.040
 Why?
Airway Extubation
1
2022
60
0.040
 Why?
Oligonucleotides
1
2002
151
0.040
 Why?
Drug Administration Schedule
2
2001
779
0.040
 Why?
Gastroesophageal Reflux
1
2024
236
0.040
 Why?
Prostaglandins
1
2001
94
0.040
 Why?
Estrogen Antagonists
1
2001
48
0.040
 Why?
Artifacts
1
2022
139
0.040
 Why?
Respiration
1
2022
206
0.040
 Why?
Cardiac Catheterization
1
2025
560
0.040
 Why?
Soluble Guanylyl Cyclase
2
2011
16
0.040
 Why?
Image Enhancement
1
2022
199
0.040
 Why?
Piperazines
3
2011
381
0.040
 Why?
Postoperative Period
1
2021
354
0.040
 Why?
Dose-Response Relationship, Drug
3
2011
2027
0.040
 Why?
Phosphatidylinositol 3-Kinases
1
2002
380
0.040
 Why?
Protoporphyrins
1
2000
14
0.040
 Why?
Injections, Intra-Arterial
1
2000
26
0.040
 Why?
Prognosis
2
2019
4282
0.040
 Why?
Epinephrine
1
2020
155
0.040
 Why?
Quinoxalines
2
2011
65
0.040
 Why?
Perioperative Period
1
2020
71
0.040
 Why?
Injections, Intramuscular
1
2000
141
0.040
 Why?
Benzodiazepines
1
2021
167
0.040
 Why?
Airway Management
1
2020
79
0.040
 Why?
Proteus
1
2019
6
0.040
 Why?
Enterobacter
1
2019
9
0.040
 Why?
Pain Management
1
2023
405
0.040
 Why?
DNA-Binding Proteins
1
2007
1499
0.040
 Why?
Transportation of Patients
1
2020
68
0.040
 Why?
Colorado
2
2020
4564
0.040
 Why?
Aftercare
1
2021
223
0.040
 Why?
Body Temperature Regulation
1
2020
108
0.040
 Why?
Hypnotics and Sedatives
1
2021
216
0.040
 Why?
Body Temperature
1
2020
229
0.040
 Why?
Contrast Media
1
2022
488
0.040
 Why?
RNA, Messenger
1
2007
2832
0.040
 Why?
Reference Values
1
2000
797
0.040
 Why?
Benchmarking
1
2020
188
0.040
 Why?
Blood Vessels
1
2000
171
0.030
 Why?
Ultrasonography, Prenatal
1
2020
294
0.030
 Why?
Receptors, Estrogen
1
2001
457
0.030
 Why?
Surgical Mesh
1
2018
50
0.030
 Why?
Cesarean Section
1
2000
224
0.030
 Why?
Infectious Disease Transmission, Vertical
1
2020
193
0.030
 Why?
Operating Rooms
1
2020
146
0.030
 Why?
Imaging, Three-Dimensional
1
2022
583
0.030
 Why?
Sterilization
1
2017
24
0.030
 Why?
Program Development
1
2020
370
0.030
 Why?
Drug Utilization
1
2018
166
0.030
 Why?
Congenital Abnormalities
1
2018
104
0.030
 Why?
Diagnosis, Differential
1
2002
1489
0.030
 Why?
Gene Expression Regulation, Developmental
1
2002
905
0.030
 Why?
Hydrogen-Ion Concentration
1
2018
561
0.030
 Why?
Acetylcholine
2
2009
204
0.030
 Why?
Risk Assessment
2
2018
3671
0.030
 Why?
Regression Analysis
1
2018
1003
0.030
 Why?
Patient Care Team
1
2021
689
0.030
 Why?
3',5'-Cyclic-GMP Phosphodiesterases
2
2005
17
0.030
 Why?
Cyclic Nucleotide Phosphodiesterases, Type 5
2
2005
23
0.030
 Why?
Sildenafil Citrate
2
2005
60
0.030
 Why?
Staphylococcus aureus
1
2019
455
0.030
 Why?
Burns
1
2020
377
0.030
 Why?
Escherichia coli
1
2019
854
0.030
 Why?
Prenatal Exposure Delayed Effects
1
2001
675
0.030
 Why?
Purines
2
2005
187
0.030
 Why?
Survival Analysis
1
2017
1382
0.020
 Why?
Cells, Cultured
2
2011
4154
0.020
 Why?
Vaccination
1
2021
1423
0.020
 Why?
Analgesics, Opioid
1
2021
1143
0.020
 Why?
Ketanserin
1
2011
12
0.020
 Why?
Serotonin 5-HT2 Receptor Antagonists
1
2011
10
0.020
 Why?
Hysterotomy
1
2011
9
0.020
 Why?
Sertraline
1
2011
27
0.020
 Why?
Receptors, Serotonin
1
2011
35
0.020
 Why?
Prostaglandin-Endoperoxide Synthases
2
2001
74
0.020
 Why?
Nitroprusside
1
2011
72
0.020
 Why?
Fluoxetine
1
2011
54
0.020
 Why?
Hypertrophy, Right Ventricular
2
2003
150
0.020
 Why?
Kidney
1
2018
1495
0.020
 Why?
Adrenal Cortex Hormones
1
2013
478
0.020
 Why?
Hydrogen Peroxide
1
2011
336
0.020
 Why?
Prospective Studies
1
2021
7990
0.020
 Why?
Constriction
1
2008
47
0.020
 Why?
Indoles
1
2011
501
0.020
 Why?
Signal Transduction
3
2006
5226
0.020
 Why?
Child, Preschool
1
2022
11787
0.020
 Why?
Regional Blood Flow
1
2008
514
0.010
 Why?
Phosphoric Diester Hydrolases
1
2004
53
0.010
 Why?
Organ Size
1
2005
463
0.010
 Why?
Heart Atria
1
2004
144
0.010
 Why?
Drug Combinations
1
2005
390
0.010
 Why?
Neovascularization, Physiologic
1
2005
194
0.010
 Why?
Blood Flow Velocity
1
2004
413
0.010
 Why?
Receptor, Platelet-Derived Growth Factor beta
1
2003
31
0.010
 Why?
Receptor, Platelet-Derived Growth Factor alpha
1
2003
54
0.010
 Why?
Meclofenamic Acid
1
2001
9
0.010
 Why?
8-Bromo Cyclic Adenosine Monophosphate
1
2001
20
0.010
 Why?
Aorta
1
2004
429
0.010
 Why?
Cyclooxygenase 1
1
2001
26
0.010
 Why?
Infusions, Intra-Arterial
1
2001
61
0.010
 Why?
Cyclooxygenase Inhibitors
1
2001
81
0.010
 Why?
Intramolecular Oxidoreductases
1
2001
66
0.010
 Why?
Pulmonary Ventilation
1
2001
83
0.010
 Why?
Cyclooxygenase 2
1
2001
165
0.010
 Why?
Organ Specificity
1
2001
312
0.010
 Why?
Ligands
1
2003
673
0.010
 Why?
Cytochrome P-450 Enzyme System
1
2001
162
0.010
 Why?
Drug Interactions
1
2001
398
0.010
 Why?
Physical Stimulation
1
2000
68
0.010
 Why?
Rats, Sprague-Dawley
1
2005
2527
0.010
 Why?
Stress, Mechanical
1
2001
494
0.010
 Why?
Muscle, Smooth
1
2000
153
0.010
 Why?
Blotting, Western
1
2001
1187
0.010
 Why?
Gene Expression
1
2003
1490
0.010
 Why?
Rats
1
2005
5597
0.010
 Why?
Grover's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (345) concept(s)
_
Co-Authors Expand Description
See all (33) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)